Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Bayesian, Universal COVID Testing

View ORCID ProfileChristian T. Meyer, View ORCID ProfileJoel M. Kralj
doi: https://doi.org/10.1101/2021.04.23.21255984
Christian T. Meyer
1BioFrontiers Institute, University of Colorado Boulder, Boulder, Colorado, 80303, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Christian T. Meyer
  • For correspondence: chme4702{at}colorado.edu
Joel M. Kralj
1BioFrontiers Institute, University of Colorado Boulder, Boulder, Colorado, 80303, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Joel M. Kralj
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

During the SARS-COV2 pandemic, there has been a persistent call for universal testing to better inform policy decisions. However, a little considered aspect of this call is the relationship between a test’s accuracy and the tested demographic. What are the implications of frequent, universal testing in otherwise asymptomatic demographics? By applying Bayesian statistics, it becomes clear that as the odds of having COVID decreases, there is a non-linear increase in the odds that each positive test is, in fact, a false positive. This phenomenon has precedence in the historical narrative surrounding universal mammogram screening which is no longer recommended due to the unacceptably high rate of false positives. The solution to combat the inflation of false positives is also suggested by Bayesian statistics: intelligently integrating multiple COVID diagnostic tests and symptoms via Bayes’ Theorem, an approach conceptually similar to pre-screening for mammograms. This extra information is readily available (e.g. olfactory function and fever) and will minimize the economic and emotional costs incurred by false positives while simultaneously improving the information available for policy-makers. In summary, along with the push for universal testing should be an equally rigorous approach to interpreting the test results.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This study was funded by the Searle Scholars Program and NIH New Innovator award (1DP2GM123458) to JMK. The funders had no role in data collection, analysis, or interpretation. This article was not paid for by a pharmaceutical company or other agency. The corresponding author (CTM) assumes full responsibility for submission.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

IRB of the University of Colorado Boulder exempted this research as no human participants were involved.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • Updated the false positive rate of the olfactory test with 96% sensitivity and 70% specificity from 82% to 85%.

Data Availability

Code required to recreate the analysis is available on request from lead author.

Data Availability

Code required to recreate the analysis is available on request from lead author.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted May 14, 2021.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Bayesian, Universal COVID Testing
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Bayesian, Universal COVID Testing
Christian T. Meyer, Joel M. Kralj
medRxiv 2021.04.23.21255984; doi: https://doi.org/10.1101/2021.04.23.21255984
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Bayesian, Universal COVID Testing
Christian T. Meyer, Joel M. Kralj
medRxiv 2021.04.23.21255984; doi: https://doi.org/10.1101/2021.04.23.21255984

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Public and Global Health
Subject Areas
All Articles
  • Addiction Medicine (434)
  • Allergy and Immunology (758)
  • Anesthesia (222)
  • Cardiovascular Medicine (3312)
  • Dentistry and Oral Medicine (366)
  • Dermatology (282)
  • Emergency Medicine (479)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1175)
  • Epidemiology (13397)
  • Forensic Medicine (19)
  • Gastroenterology (900)
  • Genetic and Genomic Medicine (5175)
  • Geriatric Medicine (482)
  • Health Economics (785)
  • Health Informatics (3283)
  • Health Policy (1145)
  • Health Systems and Quality Improvement (1198)
  • Hematology (432)
  • HIV/AIDS (1022)
  • Infectious Diseases (except HIV/AIDS) (14650)
  • Intensive Care and Critical Care Medicine (915)
  • Medical Education (478)
  • Medical Ethics (128)
  • Nephrology (525)
  • Neurology (4949)
  • Nursing (262)
  • Nutrition (734)
  • Obstetrics and Gynecology (888)
  • Occupational and Environmental Health (797)
  • Oncology (2530)
  • Ophthalmology (730)
  • Orthopedics (284)
  • Otolaryngology (348)
  • Pain Medicine (323)
  • Palliative Medicine (90)
  • Pathology (547)
  • Pediatrics (1305)
  • Pharmacology and Therapeutics (551)
  • Primary Care Research (558)
  • Psychiatry and Clinical Psychology (4223)
  • Public and Global Health (7525)
  • Radiology and Imaging (1713)
  • Rehabilitation Medicine and Physical Therapy (1018)
  • Respiratory Medicine (981)
  • Rheumatology (480)
  • Sexual and Reproductive Health (500)
  • Sports Medicine (425)
  • Surgery (551)
  • Toxicology (72)
  • Transplantation (237)
  • Urology (206)